tirzepatide for prediabetes linked to significant weight loss, 'impressive' diabetes prevention after 3 years Tirzepatide significantly reduces weight and

PMID: 21848010

That financial pressure is accelerating interest in alternatives that could bypass recurring drug costs, even if they carry higher upfront risk

Curcumin reactivates silenced tumor suppressor gene RA by reducing DNA methylation

Patient safety & quality control Compounded GLP-1 drugs have had quality variability and even unsafe/illegal versions in the market FDA is trying to ensure patients get standardized, approved formulations This aligns with FDAs core principle: approved drugs = known safety, dosing, manufacturing controls 2) Prevents copycat mass production Compounding is legally meant for special cases, not large-scale alternatives The GLP-1 boom led to industrial-scale compounding (especially via telehealth) FDA is essentially saying: this has gone beyond its intended use To me, it should be done in combination with large scale initiatives to significantly improve access and affordability

Reviews in Endocrine and Metabolic Disorders, 23(5), 979994